BGB-11417-203
Recruiting
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
BeOne Study ID
ClinicalTrials.gov ID
EudraCT Number
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents